Page last updated: 2024-10-26

racemetirosine and Behavior Disorders

racemetirosine has been researched along with Behavior Disorders in 2 studies

alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Booij, L1
Van der Does, AJ1
Riedel, WJ1
de Haan, L1
Booij, J1
Lavalye, J1
van Amelsvoort, T1
Linszen, D1

Reviews

1 review available for racemetirosine and Behavior Disorders

ArticleYear
Monoamine depletion in psychiatric and healthy populations: review.
    Molecular psychiatry, 2003, Volume: 8, Issue:12

    Topics: alpha-Methyltyrosine; Amino Acids; Biogenic Monoamines; Humans; Mental Disorders; Psychotic Disorder

2003

Other Studies

1 other study available for racemetirosine and Behavior Disorders

ArticleYear
Subjective experiences during dopamine depletion.
    The American journal of psychiatry, 2005, Volume: 162, Issue:9

    Topics: Adult; alpha-Methyltyrosine; Benzamides; Corpus Striatum; Dopamine; Enzyme Inhibitors; Humans; Iodin

2005